Cited by 288PI3K/AKT/mTOR signaling in cancerMetabolism, Diabetes, and CancerCancer, Hypoxia, and Metabolism

The DOI matches its Crossref record; 77 of the 78 references it cites were found in a registry or an index.

Insulin–PI3K signalling: an evolutionarily insulated metabolic driver of cancer

Open access

Hopkins, Benjamin D., Goncalves, Marcus D., Cantley, Lewis C.·2020·Nature Reviews Endocrinology

DOI 10.1038/s41574-020-0329-9PMC PMC7286536

Open this paper in CoChat — free account

Abstract

Cancer is driven by incremental changes that accumulate, eventually leading to oncogenic transformation. Although genetic alterations dominate the way cancer biologists think about oncogenesis, growing evidence suggests that systemic factors (for example, insulin, oestrogen and inflammatory cytokines) and their intracellular pathways activate oncogenic signals and contribute to targetable phenotypes. Systemic factors can have a critical role in both tumour initiation and therapeutic responses as increasingly targeted and personalized therapeutic regimens are used to treat patients with cancer. The endocrine system controls cell growth and metabolism by providing extracellular cues that integrate systemic nutrient status with cellular activities such as proliferation and survival via the production of metabolites and hormones such as insulin. When insulin binds to its receptor, it initiates a sequence of phosphorylation events that lead to activation of the catalytic activity of phosphoinositide 3-kinase (PI3K), a lipid kinase that coordinates the intake and utilization of glucose, and mTOR, a kinase downstream of PI3K that stimulates transcription and translation. When chronically activated, the PI3K pathway can drive malignant transformation. Here, we discuss the insulin-PI3K signalling cascade and emphasize its roles in normal cells (including coordinating cell metabolism and growth), highlighting the features of this network that make it ideal for co-option by cancer cells. Furthermore, we discuss how this signalling network can affect therapeutic responses and how novel metabolic-based strategies might enhance treatment efficacy for cancer.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41574-020-0329-9

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Self-citation
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160
On Respiratory Impairment in Cancer Cells
Warburg, O. H. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,472
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Engelman, J. A., Luo, J., & Cantley, L. C. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1879 · Cited by 3,330
Self-citation
The PI3K Pathway in Human Disease
Fruman, D. A., Chiu, H., Hopkins, B. D., Bagrodia, S., Cantley, L. C., & Abraham, R. T. (2017) · Cell · doi:10.1016/j.cell.2017.07.029 · Cited by 2,749
Self-citation
Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer
André, F., Ciruelos, E., Rubovszky, G., Campone, M., Loibl, S., Rugo, H. S., Iwata, H., Conte, P., Mayer, I. A., Kaufman, B., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1813904 · Cited by 2,622
Cancer cell metabolism: warburg and beyond
Hsu, P. P., & Sabatini, D. M. (2008) · Cell · doi:10.1016/j.cell.2008.08.021 · Cited by 2,452
Insulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059

Show all 78 references

Sorted by citations

Regulation and metabolic functions of mTORC1 and mTORC2
Szwed, A., Kim, E., & Jacinto, E. (2021) · Physiological Reviews · doi:10.1152/physrev.00026.2020 · Cited by 855
Tumour fatty acid metabolism in the context of therapy resistance and obesity
Hoy, A. J., Nagarajan, S. R., & Butler, L. M. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00388-4 · Cited by 415
Obesity, Diabetes, and Increased Cancer Progression
Kim, D.-S., & Scherer, P. E. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0077 · Cited by 322
Linoleic acid potentiates CD8+ T cell metabolic fitness and antitumor immunity
Lauson, C. B. N., Tiberti, S., Corsetto, P. A., Conte, F., Tyagi, P., Machwirth, M., Ebert, S., Loffreda, A., Scheller, L., Sheta, D., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.02.013 · Cited by 302
Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression
Xue, C., Li, G., Lü, J., & Li, L. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00788-w · Cited by 266
Obesity, Type 2 Diabetes, and Cancer Risk
Scully, T., Ettela, A., LeRoith, D., & Gallagher, E. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.615375 · Cited by 289
Insulin Resistance and Diabetes Mellitus in Alzheimer’s Disease
Burillo, J., Marqués, P., Jiménez, B., González-Blanco, C., Benito, M., & Guillén, C. (2021) · Cells · doi:10.3390/cells10051236 · Cited by 246
Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer
Petroni, G., Cantley, L. C., Santambrogio, L., Formenti, S. C., & Galluzzi, L. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00579-w · Cited by 224
Self-citation
Mechanisms underlying the pathophysiology of type 2 diabetes: From risk factors to oxidative stress, metabolic dysfunction, and hyperglycemia
Lima, J. E. B. F., Moreira, N. C. S., & Sakamoto-Hojo, E. T. (2022) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2021.503437 · Cited by 203
Mammalian lipids: structure, synthesis and function
Cockcroft, S. (2021) · Essays in Biochemistry · doi:10.1042/ebc20200067 · Cited by 201
Phosphatidylinositol(4,5)bisphosphate: diverse functions at the plasma membrane
Katan, M., & Cockcroft, S. (2020) · Essays in Biochemistry · doi:10.1042/ebc20200041 · Cited by 176
Is it still worth pursuing the repurposing of metformin as a cancer therapeutic?
Lord, S., & Harris, A. L. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02204-2 · Cited by 139
AMPK regulation of Raptor and TSC2 mediate metformin effects on transcriptional control of anabolism and inflammation
Van Nostrand, J. L., Hellberg, K., Luo, E.-C., Van Nostrand, E. L., Dayn, A., Yu, J., Shokhirev, M. N., Dayn, Y., Yeo, G. W., & Shaw, R. J. (2020) · Genes & Development · doi:10.1101/gad.339895.120 · Cited by 111
Insulin Resistance: The Increased Risk of Cancers
Szablewski, L. (2024) · Current Oncology · doi:10.3390/curroncol31020075 · Cited by 123
PI3K drives the de novo synthesis of coenzyme A from vitamin B5
Dibble, C. C., Barritt, S. A., Perry, G. E., Lien, E. C., Geck, R. C., DuBois-Coyne, S. E., Bartee, D., Zengeya, T. T., Cohen, E. B., Yuan, M., et al. (2022) · Nature · doi:10.1038/s41586-022-04984-8 · Cited by 102
Self-citation
PI3K/AKT/mTOR Dysregulation and Reprogramming Metabolic Pathways in Renal Cancer: Crosstalk with the VHL/HIF Axis
Bădoiu, S. C., Greabu, M., Miricescu, D., Stănescu-Spînu, I.-I., Ilinca, R., Bălan, D. G., Balcangiu‐Stroescu, A.-E., Mihai, D. A., Văcăroiu, I. A., Ștefani, C., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098391 · Cited by 101
Mentha: Nutritional and Health Attributes to Treat Various Ailments Including Cardiovascular Diseases
Saqib, S., Ullah, F., Naeem, M. S., Younas, M., Ayaz, A., Ali, S., & Zaman, W. (2022) · Molecules · doi:10.3390/molecules27196728 · Cited by 96
TGF‐β ‐induced PI3K / AKT / mTOR pathway controls myofibroblast differentiation and secretory phenotype of valvular interstitial cells through the modulation of cellular senescence in a naturally occurring in vitro canine model of myxomatous mitral valve disease
Tang, Q., Markby, G. R., MacNair, A. J., Tang, K., Tkacz, M., Parys, M., Phadwal, K., MacRae, V. E., & CORCORAN, B. M. (2023) · Cell Proliferation · doi:10.1111/cpr.13435 · Cited by 83
Insulin and cancer: a tangled web
Leitner, B. P., Siebel, S., Akingbesote, N. D., Zhang, X., & Perry, R. J. (2022) · Biochemical Journal · doi:10.1042/bcj20210134 · Cited by 79
Polyphenolic Proanthocyanidin-B2 suppresses proliferation of liver cancer cells and hepatocellular carcinogenesis through directly binding and inhibiting AKT activity
Liu, G., Shi, A., Wang, N., Li, M., He, X., Yin, C., Tu, Q., Shen, X., Tao, Y., Wang, Q., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101701 · Cited by 79
Effects of novel SGLT2 inhibitors on cancer incidence in hyperglycemic patients: a meta-analysis of randomized clinical trials
Benedetti, R., Benincasa, G., Glass, K., Chianese, U., Vietri, M. T., Congi, R., Altucci, L., & Claudio Napoli, A. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.106039 · Cited by 75
Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studies
Ji, Z., Shen, J., Lan, Y., Yi, Q., & Liu, H. (2023) · MedComm · doi:10.1002/mco2.308 · Cited by 71
Obesity and gynecological cancers: A toxic relationship
Wichmann, I. A., & Cuello, M. A. (2021) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13870 · Cited by 63
Autophagy counters inflammation-driven glycolytic impairment in aging hematopoietic stem cells
Dellorusso, P. V., Proven, M. A., Calero‐Nieto, F. J., Wang, X., Mitchell, C. A., Hartmann, F. J., Amouzgar, M., Favaro, P. M. B., DeVilbiss, A., Swann, J. W., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.04.020 · Cited by 66
Fructose‐1,6‐Bisphosphate Aldolase B Depletion Promotes Hepatocellular Carcinogenesis Through Activating Insulin Receptor Signaling and Lipogenesis
Liu, G., Wang, N., Zhang, C., Li, M., He, X., Yin, C., Tu, Q., Shen, X., Zhang, L., Lv, J., et al. (2021) · Hepatology · doi:10.1002/hep.32064 · Cited by 61
Properties of FDA-approved small molecule phosphatidylinositol 3-kinase inhibitors prescribed for the treatment of malignancies
Roskoski, R. J. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105579 · Cited by 62
Function and Regulation of the Epithelial Na + Channel ENaC
Rotin, D., & Staub, O. (2021) · Comprehensive physiology · doi:10.1002/cphy.c200012 · Cited by 79
Obesity promotes breast epithelium DNA damage in women carrying a germline mutation in BRCA1 or BRCA2
Bhardwaj, P., Iyengar, N. M., Zahid, H., Carter, K. M., Byun, D. J., Choi, M. H., Sun, Q., Savenkov, O., Louka, C., Liu, C., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.ade1857 · Cited by 58
Self-citation
A landscape of response to drug combinations in non-small cell lung cancer
Nair, N. U., Greninger, P., Zhang, X., Friedman, A. A., Amzallag, A., Cortez, E., Sahu, A. D., Lee, J. S., Dastur, A., Egan, R. K., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39528-9 · Cited by 63
Relationship between diabetes and risk of gastric cancer: A systematic review and meta-analysis of cohort studies
Guo, J., Liu, C., Pan, J., & Yang, J. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109866 · Cited by 57
Altered m 6 A modification is involved in up‐regulated expression of FOXO3 in luteinized granulosa cells of non‐obese polycystic ovary syndrome patients
Zhang, S., Deng, W.-L., Liu, Q., Wang, P., Yang, W., & Ni, W. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15807 · Cited by 56
Revisiting Glycogen in Cancer: A Conspicuous and Targetable Enabler of Malignant Transformation
Khan, T., Sullivan, M. A., Gunter, J. H., Kryza, T., Lyons, N., He, Y., & Hooper, J. D. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.592455 · Cited by 60
Somatic PIK3R1 variation as a cause of vascular malformations and overgrowth
Cottrell, C. E., Bender, N. R., Zimmermann, M. T., Heusel, J. W., Corliss, M. M., Evenson, M. J., Magrini, V. J., Corsmeier, D. J., Avenarius, M. R., Dudley, J. N., et al. (2021) · Genetics in Medicine · doi:10.1038/s41436-021-01211-z · Cited by 55
A central role for STAT5 in the transcriptional programing of T helper cell metabolism
Villarino, A. V., Laurence, A. D. J., Davis, F. P., Nivelo, L. A., Brooks, S. R., Sun, H., Jiang, K., Afzali, B., Frasca, D., Hennighausen, L. G., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abl9467 · Cited by 56
Homeostatic regulation of NAD(H) and NADP(H) in cells
Chen, L., Xing, X., Zhang, P., Chen, L., & Pei, H. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.101146 · Cited by 57
Mechanisms of insulin resistance, mitochondrial dysfunction and the action of the ketogenic diet in bipolar disorder. Focus on the PI3K/AKT/HIF1-a pathway
Campbell, I. H., & Campbell, H. J. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110299 · Cited by 56
MicroRNA-21 deficiency suppresses prostate cancer progression through downregulation of the IRS1-SREBP-1 signaling pathway
Kanagasabai, T., Li, G., Shen, T. H., Gladoun, N., Castillo-Martín, M., Celada, S. I., Xie, Y., Brown, L. K., Mark, Z. A., Ochieng, J., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.09.041 · Cited by 52
Endosomal trafficking in metabolic homeostasis and diseases
Gilleron, J., & Zeigerer, A. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00737-9 · Cited by 57
Diabetes and the associated complications: The role of antioxidants in diabetes therapy and care
Dilworth, L., Stennett, D., Facey, A., Omoruyi, F. O., Mohansingh, S., & Omoruyi, F. O. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117641 · Cited by 71
Early-onset colorectal cancer as an emerging disease of metabolic dysregulation
Du, M., Drew, D. A., Goncalves, M. D., Cao, Y., & Chan, A. T. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01159-z · Cited by 51
Self-citation
Bruton’s Tyrosine Kinase and Its Isoforms in Cancer
Wang, X., Kokabee, L., Kokabee, M., & Conklin, D. S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.668996 · Cited by 48
Associations between Diabetes Mellitus and Selected Cancers
Pliszka, M., & Szablewski, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137476 · Cited by 53
Mechanistic Target of Rapamycin Complex 1: From a Nutrient Sensor to a Key Regulator of Metabolism and Health
Wang, G., Chen, L., Qin, S., Zhang, T., Yao, J., Yi, Y., & Deng, L. (2022) · Advances in Nutrition · doi:10.1093/advances/nmac055 · Cited by 45
Externalized phosphatidylinositides on apoptotic cells are eat-me signals recognized by CD14
Kim, O., Kang, G.-H., Hur, J., Lee, J. W., Jung, Y., Hong, I., Lee, H., Seo, S., Lee, D. H., Lee, C.-S., et al. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00931-2 · Cited by 49
Atherosclerosis, Diabetes Mellitus, and Cancer: Common Epidemiology, Shared Mechanisms, and Future Management
Katsi, V. K., Papakonstantinou, I. P., & Tsioufis, K. P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411786 · Cited by 43
Advances in dietary polysaccharides as hypoglycemic agents: mechanisms, structural characteristics, and innovative applications
Zhang, Y., Lü, J., Li, H., & Song, H. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2293254 · Cited by 42
AKT1 phosphorylation of cytoplasmic ME2 induces a metabolic switch to glycolysis for tumorigenesis
Chen, T., Xie, S., Cheng, J., Zhao, Q. L., Wu, H., Jiang, P., & Du, W. (2024) · Nature Communications · doi:10.1038/s41467-024-44772-8 · Cited by 42
Antagonistic effects of IL-17 and Astragaloside IV on cortical neurogenesis and cognitive behavior after stroke in adult mice through Akt/GSK-3β pathway
Sun, L., Han, R., Guo, F., Chen, H., Wang, W., Chen, Z., Liu, W., Sun, X., & Gao, C. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00298-8 · Cited by 42
Endometrial Cancer as a Metabolic Disease with Dysregulated PI3K Signaling: Shedding Light on Novel Therapeutic Strategies
Kyo, S., & Nakayama, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176073 · Cited by 44
Effects of T2DM on cancer progression: pivotal precipitating factors and underlying mechanisms
Zhang, Y., Li, Y., Xue, C., Li, S., Gao, Z., & Qin, K. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1396022 · Cited by 45
Adipose MSCs Suppress MCF7 and MDA-MB-231 Breast Cancer Metastasis and EMT Pathways Leading to Dormancy via Exosomal-miRNAs Following Co-Culture Interaction
Ali, N. M., Yeap, S. K., Ho, W. Y., Boo, L., Kỳ, H., Satharasinghe, D. A., Tan, S. W., Cheong, S. K., Huang, H. D., Lan, K.-C., et al. (2020) · Pharmaceuticals · doi:10.3390/ph14010008 · Cited by 41
The Role of Dysfunctional Adipose Tissue in Pancreatic Cancer: A Molecular Perspective
Brocco, D., Florio, R., Lellis, L. D., Veschi, S., Grassadonia, A., Tinari, N., & Cama, A. (2020) · Cancers · doi:10.3390/cancers12071849 · Cited by 40
MASH as an emerging cause of hepatocellular carcinoma: current knowledge and future perspectives
Karin, M., & Kim, J. Y. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13685 · Cited by 45
Cancer metabolism and dietary interventions
Qian, L., Zhang, F., Yin, M., & Lei, Q. (2021) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2021.0461 · Cited by 40
The Potential Role of C-Reactive Protein in Metabolic-Dysfunction-Associated Fatty Liver Disease and Aging
Ding, Z., Wei, Y., Peng, J., Wang, S., Chen, G., & Sun, J. (2023) · Biomedicines · doi:10.3390/biomedicines11102711 · Cited by 40
Artesunate ameliorates irinotecan-induced intestinal injury by suppressing cellular senescence and significantly enhances anti-tumor activity
Jia, H. J., Bai, S.-R., Xia, J., He, S. Y., Dai, Q., Zhou, M., & Wang, X. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110205 · Cited by 35
Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs
Wang, H., Tan, H., Zhan, W., Song, L., Zhang, D., Chen, X., Lin, Z., Wang, W., Yang, Y., Wang, L., et al. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114056 · Cited by 34
Therapeutic Drug-Induced Metabolic Reprogramming in Glioblastoma
Nguyen, T. T. T., Shang, E., Westhoff, M., Karpel‐Massler, G., & Siegelin, M. D. (2022) · Cells · doi:10.3390/cells11192956 · Cited by 32
Eukaryotic cell size regulation and its implications for cellular function and dysfunction
Chadha, Y., Khurana, A., & Schmoller, K. M. (2024) · Physiological Reviews · doi:10.1152/physrev.00046.2023 · Cited by 31
Insertion of a synthetic switch into insulin provides metabolite-dependent regulation of hormone–receptor activation
Chen, Y., Gleaton, J., Yang, Y., Dhayalan, B., Phillips, N. B., Liu, Y., Broadwater, L., Jarosinski, M. A., Chatterjee, D., Lawrence, M. C., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2103518118 · Cited by 34
Organismal metabolism regulates the expansion of oncogenic PIK3CA mutant clones in normal esophagus
Herms, A., Colom, B., Piedrafita, G., Kalogeropoulou, A., Banerjee, U., King, C., Abby, E., Murai, K., Caseda, I., Fernández‐Antorán, D., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01891-8 · Cited by 33
Implications of obesity and insulin resistance for the treatment of oestrogen receptor-positive breast cancer
Javed, S. R., Skolariki, A., Zameer, M. Z., & Lord, S. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02833-1 · Cited by 38
PI3Kβ functions as a protein kinase to promote cellular protein O-GlcNAcylation and acetyl-CoA production for tumor growth
He, X., Chen, D., Liu, G., Wu, Q., Zhao, H., Guo, D. S., Jiang, X., Li, M., Meng, Y., Yin, Y., et al. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.02.024 · Cited by 32
ErBb Family Proteins in Cholangiocarcinoma and Clinical Implications
Jin, W. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072255 · Cited by 33
Targeting the PI3K/AKT signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020–2023)
Sabbah, D. A., Hajjo, R., Bardaweel, S. K., & Zhong, H. A. (2024) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2024.2338100 · Cited by 34
Spatiotemporal regulation of insulin signaling by liquid–liquid phase separation
Zhou, K., Chen, Q., Chen, J., Liang, D., Feng, W., Liu, M., Wang, Q., Wang, R., Ouyang, Q., Quan, C., et al. (2022) · Cell Discovery · doi:10.1038/s41421-022-00430-1 · Cited by 31
Characterization of Fatty Acid Metabolism-Related Genes Landscape for Predicting Prognosis and Aiding Immunotherapy in Glioma Patients
Jiang, F., Luo, F., Zeng, N., Mao, Y., Tang, X., Wang, J., Hu, Y., & Wu, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.902143 · Cited by 28
The Pathological Mechanisms and Therapeutic Molecular Targets in Arteriovenous Fistula Dysfunction
Yan, R., Song, A., & Zhang, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179519 · Cited by 27
Discovery of Pyridopyrimidinones that Selectively Inhibit the H1047R PI3Kα Mutant Protein
Ketcham, J. M., Harwood, S. J., Aranda, R., Aloiau, A. N., Bobek, B. M., Briere, D. M., Burns, A. C., Haatveit, K. C., Calinisan, A., Clarine, J., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00078 · Cited by 26
Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer
Rocca, A., Cortesi, P., Cortesi, L., Gianni, L., Matteucci, F., Fantini, L., Maestri, A., Giunchi, D. C., Cavanna, L., Ciani, R., et al. (2021) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920985632 · Cited by 23
Dietary Control of Inflammation and Resolution
Sears, B., & Saha, A. K. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.709435 · Cited by 30
Metformin counteracts stimulatory effects induced by insulin in primary breast cancer cells
Scordamaglia, D., Cirillo, F., Talia, M., Santolla, M. F., Rigiracciolo, D. C., Muglia, L., Zicarelli, A., Rosis, S. D., Giordano, F., Miglietta, A., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03463-y · Cited by 28
PI3K and AKT at the Interface of Signaling and Metabolism
Solinas, G., & Becattini, B. (2022) · Current topics in microbiology and immunology · doi:10.1007/978-3-031-06566-8_13 · Cited by 27
Tumor Cell-Intrinsic Immunometabolism and Precision Nutrition in Cancer Immunotherapy
Cuyàs, E., Verdura, S., Martín-Castillo, B., Alarcón, T., Lupu, R., Bosch‐Barrera, J., & Menéndez, J. A. (2020) · Cancers · doi:10.3390/cancers12071757 · Cited by 26
The Role of Insulin Regulated Aminopeptidase in Endocytic Trafficking and Receptor Signaling in Immune Cells
Descamps, D., Evnouchidou, I., Caillens, V., Drajac, C., Riffault, S., Endert, P. V., & Saveanu, L. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.583556 · Cited by 28
The G-Protein Rab5A Activates VPS34 Complex II, a Class III PI3K, by a Dual Regulatory Mechanism
Buckles, T. C., Ohashi, Y., Tremel, S., McLaughlin, S. H., Pardon, E., Steyaert, J., Gordon, M. T., Williams, R. L., & Falke, J. J. (2020) · Biophysical Journal · doi:10.1016/j.bpj.2020.10.028 · Cited by 24
Structural insights into Ras regulation by SIN1
Zheng, Y., Ding, L., Meng, X., Potter, M., Kearney, A. L., Zhang, J., Sun, J., James, D. E., Yang, G., & Zhou, C. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2119990119 · Cited by 25
Implications of receptor for advanced glycation end products for progression from obesity to diabetes and from diabetes to cancer
Garza-Campos, A., Prieto-Correa, J. R., Domínguez-Rosales, J. A., & Nazará, Z. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i7.977 · Cited by 27
Beyond energy and growth: the role of metabolism in developmental signaling, cell behavior and diapause
Tippetts, T. S., Sieber, M., & Solmonson, A. (2023) · Development · doi:10.1242/dev.201610 · Cited by 25
Doxorubicin-sensitive and -resistant colorectal cancer spheroid models: assessing tumor microenvironment features for therapeutic modulation
Valente, R., Cordeiro, S. Z., Luz, A., Melo, M. C., Roma‐Rodrigues, C., Baptista, P. V., & Fernandes, A. R. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1310397 · Cited by 25
mTOR Signaling in Aquaculture Animals: A Central Nutrient‐Sensing Hub Orchestrating Growth, Metabolism, Health and Quality
Liu, Y., Mai, K., & Zhang, W. (2025) · Reviews in Aquaculture · doi:10.1111/raq.70068 · Cited by 23
Incidence of human papillomavirus‐related anogenital precancer and cancer in women with diabetes: A nationwide registry‐based cohort study
Reinholdt, K., Thomsen, L. T., Munk, C., Dehlendorff, C., Aalborg, G. L., Carstensen, B., Jørgensen, M. E., & Kjær, S. K. (2020) · International Journal of Cancer · doi:10.1002/ijc.33365 · Cited by 23
Aberrant lipid metabolism in cancer cells and tumor microenvironment: the player rather than bystander in cancer progression and metastasis
Yu, X., Mi, S., Ye, J., & Lou, G. (2021) · Journal of Cancer · doi:10.7150/jca.64833 · Cited by 24
A phase 1 safety and feasibility trial of a ketogenic diet plus standard of care for patients with recently diagnosed glioblastoma
Amaral, L. J., Gresham, G. K., Kim, S., Tighiouart, M., Nelson, T. A., Welborn, A., Lockshon, L., Noorvash, B., Rudnick, J. D., Irwin, S. A., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-06675-6 · Cited by 22
Type-2 diabetes mellitus-associated cancer risk: In pursuit of understanding the possible link
Vulichi, S. R., Runthala, A., Nagaraju, B., Kumar, R., Chunduri, V. R., Kapur, S., Chippada, A. R., & Sistla, D. S. M. (2022) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2022.102591 · Cited by 23
Metabolic interventions combined with CTLA-4 and PD-1/PD-L1 blockade for the treatment of tumors: mechanisms and strategies
Liao, L., Xu, H., Zhao, Y., & Zheng, X. (2023) · Frontiers of Medicine · doi:10.1007/s11684-023-1025-7 · Cited by 22
Growth hormone receptor disrupts glucose homeostasis via promoting and stabilizing retinol binding protein 4
Liu, J., Nie, C., Xue, L., Yan, Y., Liu, S., Sun, J., Fan, M., Qian, H., Ying, H., Wang, L., et al. (2021) · Theranostics · doi:10.7150/thno.61192 · Cited by 22
Molecular Impact of Metabolic and Endocrine Disturbance on Endometrial Function in Polycystic Ovary Syndrome
Parker, J., O'Brien, C. L., Uppal, T., & Tremellen, K. P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26209926 · Cited by 25
N-linked glycosylation is essential for anti-tumor activities of KIAA1324 in gastric cancer
Yun, R., Hong, E., Kim, J., Park, B., Kim, S. J., Lee, B., Song, Y. S., Kim, S., Park, S., & Kang, J. M. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06083-6 · Cited by 21
Metformin and the PI3K/AKT signaling pathway: implications for cancer, cardiovascular, and central nervous system diseases
Ahmadabad, H. A., Panah, S. M., Ghasemnejad‐Berenji, H., Ghojavand, S., Ghasemnejad‐Berenji, M., & Khezri, M. R. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03358-3 · Cited by 20
Betulinic Acid Suppresses de novo Lipogenesis by Inhibiting Insulin and IGF1 Signaling as Upstream Effectors of the Nutrient-Sensing mTOR Pathway
Kim, H. K., Park, Y., Shin, M., Kim, J., & Go, G. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c04797 · Cited by 20
Leukemia inhibitory factor drives glucose metabolic reprogramming to promote breast tumorigenesis
Yue, X., Wang, J., Chang, C., Liu, J., Yang, X. F., Zhou, F., Qiu, X., Bhatt, V. D., Guo, J. Y., Su, X., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04820-x · Cited by 20
Correlation of PTEN signaling pathway and miRNA in breast cancer
Mohammadi, M., Fazilat, A., Mamalo, A. S., Ojarudi, M., Hemmati-Dinarvand, M., Beilankouhi, E. A. V., & Valilo, M. (2024) · Molecular Biology Reports · doi:10.1007/s11033-023-09191-w · Cited by 20
Obesity and cholangiocarcinoma: A review of epidemiological and molecular associations
Osataphan, S. A., Mahankasuwan, T., & Saengboonmee, C. (2021) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.1001 · Cited by 20
Grainyhead 1 acts as a drug-inducible conserved transcriptional regulator linked to insulin signaling and lifespan
Grigolon, G., Araldi, E., Erni, R., Wu, J. Y., Thomas, C., Fortezza, M. L., Laube, B., Pöhlmann, D., Stoffel, M., Zarse, K., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27732-4 · Cited by 21
Transcriptional programing of T cell metabolism by STAT family transcription factors
Villarino, A. V. (2023) · European Journal of Immunology · doi:10.1002/eji.202048825 · Cited by 19
YTHDF2 inhibit the tumorigenicity of endometrial cancer via downregulating the expression of IRS1 methylated with m6A
Hong, L., Pu, X., Gan, H., Weng, L., & Zheng, Q. (2021) · Journal of Cancer · doi:10.7150/jca.54527 · Cited by 19
Type 2 Diabetes and Risk of Early-Onset Colorectal Cancer
Li, Z., Chen, H., Fritz, C. D. L., Zheng, X., Zong, X., Nickel, K. B., Tipping, A. D., Nguyen, L. H., Chan, A. T., Giovannucci, E. L., et al. (2022) · Gastro Hep Advances · doi:10.1016/j.gastha.2021.10.009 · Cited by 19
Discovery of Novel Phosphoinositide-3-Kinase α Inhibitors with High Selectivity, Excellent Bioavailability, and Long-Acting Efficacy for Gastric Cancer
Hou, Y., Zhang, F., Min, W., Yuan, K., Kuang, W., Wang, X., Zhu, Y., Sun, C., Xia, F., Wang, Y., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00549 · Cited by 18
UCHL1 aggravates skin fibrosis through an IGF ‐1‐induced Akt/ mTOR / HIF ‐1α pathway in keloid
Guo, C., Liang, L., Zheng, J.-B., Xie, Y., Qiu, X., Tan, G., Huang, J., & Wang, L. (2023) · The FASEB Journal · doi:10.1096/fj.202300153rr · Cited by 18

Authors: Hopkins, B. D., Goncalves, M. D., & Cantley, L. C.
Affiliations: Icahn School of Medicine at Mount Sinai (US)
Weill Cornell Medicine (US)
Corresponding author: Hopkins, Benjamin D.
ORCID: Hopkins, Benjamin D.
Goncalves, Marcus D.
Cantley, Lewis C.
Venue: Nature Reviews Endocrinology
Publisher: Springer Science and Business Media LLC
Published: 2020-03-03
Volume: 16
Issue: 5
Pages: 276-283
ISSN: 1759-5029 (ISSN-L)
1759-5037
DOI: 10.1038/s41574-020-0329-9
PMC: PMC7286536
OpenAlex: W3009258273
Cited by: 288
References: 78
Citations by year: 2026: 34 · 2025: 50 · 2024: 46 · 2023: 52 · 2022: 45 · 2021: 41 · 2020: 20
FWCI: 3.81
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature Reviews Endocrinology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Cancer Institute (K08CA230318, R00CA230384, R35CA197588)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Keywords: insulin signaling, PI3K signaling, mTOR, oncogenic transformation, cancer metabolism, insulin resistance, insulin receptor, cancer therapy resistance, metabolic targeting, tumor initiation
MeSH terms: Animals, Endocrine System, Biological Evolution, Humans, Insulin, Neoplasms, Signal Transduction, Phosphatidylinositol 3-Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Insulin–PI3K signalling: an evolutionarily insulated metabolic driver of cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks